Cyclopharm Ltd CYC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$1.75
- Day Range
- A$1.75–1.75
- 52-Week Range
- A$1.72–3.15
- Bid/Ask
- A$1.75 / A$1.79
- Market Cap
- A$164.83 Mil
- Volume/Avg
- 220 / 23,268
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.16
- Dividend Yield (Trailing)
- 0.56%
- Dividend Yield (Forward)
- 0.56%
- Total Yield
- 0.57%
Company Profile
Cyclopharm Ltd is a company that engages in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. It operates through the following segments. The Technegas segment involves supplying diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism, and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment offers to produce radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders, and cardiac disease. The firm generates maximum revenue from the Technegas segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 63
- Website
- https://cyclopharm.com.au
Comparables
Valuation
|
Metric
|
CYC
|
603387
|
688656
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 23.55 | 432.38 |
Price/Book Value | 5.10 | 1.82 | 1.97 |
Price/Sales | 6.16 | 3.16 | 4.37 |
Price/Cash Flow | — | 10.84 | 18.52 |
Price/Earnings
CYC
603387
688656
Financial Strength
|
Metric
|
CYC
|
603387
|
688656
|
|---|---|---|---|
Quick Ratio | 2.96 | 1.39 | 1.81 |
Current Ratio | 3.90 | 2.26 | 2.68 |
Interest Coverage | −30.96 | 16.15 | 16.56 |
Quick Ratio
CYC
603387
688656
Profitability
|
Metric
|
CYC
|
603387
|
688656
|
|---|---|---|---|
Return on Assets (Normalized) | −13.73% | 5.42% | 0.40% |
Return on Equity (Normalized) | −18.60% | 7.96% | 0.47% |
Return on Invested Capital (Normalized) | −16.80% | 6.33% | 0.56% |
Return on Assets
CYC
603387
688656
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Ntbvvyynv | Gqwlj | $185.4 Bil | |
SYK
| Stryker Corp | Qzfycttw | Fyzvc | $128.2 Bil | |
BSX
| Boston Scientific Corp | Vszlrmmg | Tvrhvd | $107.7 Bil | |
MDT
| Medtronic PLC | Rxkcwwck | Xrcrvz | $105.2 Bil | |
DXCM
| DexCom Inc | Cdrglzgh | Lzrk | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Qxtlkbdt | Mtdjpxr | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Rhcgcbxqx | Ghmgs | $24.6 Bil | |
ALGN
| Align Technology Inc | Nhqqdkdp | Fqnxt | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Glmhbpqlx | Pzkfx | $18.7 Bil | |
PODD
| Insulet Corp | Qvscgnwh | Wkdyr | $11.5 Bil |